To compile characteristics of real-world clinical outcomes for Boston Scientific commercially approved neurostimulation systems for pain in routine clinical practice, when used according to the applicable Directions for Use - and - To evaluate the economic value and technical performance of Boston Scientific commercially approved neurostimulation systems for pain in routine clinical practice

Population

Subjects who exhibit an on-label indication for neurostimulation to relieve chronic intractable pain, according to the Directions for Use, as applicable in each country or region

Brief Title

RELIEF - A Global Registry to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain

Official Title

A Global Registry to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain

Brief Summary

To compile characteristics of real-world clinical outcomes for Boston Scientific commercially <br /> approved neurostimulation systems for pain in routine clinical practice, when used according <br /> to the applicable Directions for Use <br /> <br /> - and - <br /> <br /> To evaluate the economic value and technical performance of Boston Scientific commercially <br /> approved neurostimulation systems for pain in routine clinical practice

Detailed Description

The study is a prospective, multi-center, global registry of Boston Scientific
neurostimulation systems for pain.

The study treatment will consist of neurostimulation trial therapy with any commercially
approved Boston Scientific Corporation neurostimulator for pain. Positive trials, subjects
with a successful trial outcome, may progress to permanent implant of a neurostimulation
system. Individualization of neurostimulation therapy for pain will be determined according
to investigator discretion and site routine care, and in accordance with inclusion and
exclusion criteria.

Outcome Measures

Outcome measures are the tests that investigators perform to prove whether or not a treatment being tested in a clinical trial is having any effect.